Pulmonx Corporation LUNG Weighted Average Exercise Price of Vested and Expected to Vest Options
Weighted Average Exercise Price of Vested and Expected to Vest Options at other companies
Other financials
Where this comes from
Reported directly by Pulmonx Corporation in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.
The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulmonx Corporation's weighted average exercise price of vested and expected to vest options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pulmonx Corporation's weighted average exercise price of vested and expected to vest options?
- Pulmonx Corporation (LUNG) reported weighted average exercise price of vested and expected to vest options of $16.73 in Q1 2026.
- How has Pulmonx Corporation's weighted average exercise price of vested and expected to vest options changed year-over-year?
- Pulmonx Corporation's weighted average exercise price of vested and expected to vest options increased by 16.5% year-over-year, from $14.36 to $16.73.